Gilbert + Tobin is advising the Joint Lead Managers to the Healthscope IPO, Macquarie Capital (Australia) Limited, UBS AG (Australia Branch), CIMB Capital Markets (Australia) Ltd, Credit Suisse (Australia) Limited, Goldman Sachs Australia Pty Limited and Merrill Lynch Equities (Australia) Limited. The listing will give Healthscope an implied market capitalisation of $3.3 – $3.8 billion at the offer price, making this the largest IPO in Australia since QR National in 2010.
Tags: Gilbert, LLP
Kirkland & Ellis International LLP represented Braas Monier Building Group SA and its stakeholders, including Apollo Management, TowerBrook Capital Partners and York Capital Management, in connection with Braas Monier’s recent refinancing and high-yield bond offering, and the initial public offering of the business on the Frankfurt Stock Exchange earlier this week. The partial listing raised €470 million (approx. $639 million) and valued Monier at €940 million (approx. $1.28 billion).
More >>
Merz and Ulthera, Inc. announced on June 26, 2014 that they have entered a definitive merger agreement pursuant to which Merz will acquire Ulthera, Inc, a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications using its therapeutic ultrasound platform technology. Valued at up to $600 million in upfront cash and milestone payments, the acquisition is the largest in Merz’s history.
Tags: Knobbe Martens
Leading international law firm Clifford Chance is advising AA plc (the UK’s leading roadside assistance provider) and its owner Acromas Holdings, on its IPO on the London Stock Exchange, which has raised £1.385billion.
Tags: Clifford Chance LLPCravath represented the underwriters, led by J.P. Morgan Securities, Goldman, Sachs & Co., BofA Merrill Lynch and Citigroup, in connection with the US$552 million registered common stock offering of CoStar Group, Inc., a leading provider of information and analytic services to the commercial real estate industry in the United States and the United Kingdom. The shares were listed on the NASDAQ Global Select Market. The transaction closed on June 11, 2014.
Paul Hastings LLP, a leading global law firm, announced today that the firm represented UBS AG, Stamford Branch as administrative agent, lender and issuing bank and UBS Securities LLC and Macquarie Capital (USA) Inc. as joint lead arrangers and joint bookrunners in connection with a recapitalization of World Triathlon Corporation, which owns and licenses the Ironman brand.
The financing consists of a $225 million term loan facility and a $20 million revolving credit facility.
More >>
